Protective effect of SARS‐CoV‐2 preventive measures against ESKAPE and Escherichia coli infections-Reference-Cited by-同舟云学术

Protective effect of SARS‐CoV‐2 preventive measures against ESKAPE and Escherichia coli infections

Published:2021-10-11 Issue:12 Volume:51 Page:
ISSN:0014-2972
Container-title:European Journal of Clinical Investigation
language:en
Short-container-title:Eur J Clin Invest

Author:

Gaspari Rita¹²^ORCID,Spinazzola Giorgia¹²^ORCID,Teofili Luciana³⁴^ORCID,Avolio Alfonso W.⁵⁶^ORCID,Fiori Barbara⁷^ORCID,Maresca Gian M¹^ORCID,Spanu Teresa²⁷^ORCID,Nicolotti Nicola⁸^ORCID,De Pascale Gennaro¹²^ORCID,Antonelli Massimo¹²^ORCID

Affiliation:

1. Dipartimento di Scienze dell'Emergenza Anestesiologiche e della Rianimazione Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italy

2. Dipartimento di Scienze Biotecnologiche di Base Cliniche Intensivologiche e Perioperatorie Università Cattolica del Sacro Cuore Roma Italy

3. Dipartimento di Diagnostica per Immagini Radioterapia Oncologica ed Ematologica Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italy

4. Dipartimento di Scienze radiologiche ed Ematologiche Università Cattolica del Sacro Cuore Roma Italy

5. Dipartimento di Scienze Mediche e Chirurgiche Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italy

6. Dipartimento di Medicina e Chirurgia Traslazionale Università Cattolica del Sacro Cuore Roma Italy

7. Dipartimento di Scienze di laboratorio e Infettivologiche Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italy

8. Direzione Sanitaria Fondazione Policlinico Universitario A. Gemelli IRCCS Roma Italy

Publisher

Wiley

Subject

Clinical Biochemistry,Biochemistry,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/eci.13687

Reference15 articles.

1. Federal Funding for the Study of Antimicrobial Resistance in Nosocomial Pathogens: No ESKAPE

2. Incidence and antimicrobial resistance trends in bloodstream infections caused by ESKAPE and Escherichia coli at a large teaching hospital in Rome, a 9-year analysis (2007–2015)

3. Antimicrobial Resistance in ESKAPE Pathogens

4. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital‐acquired pneumonia and ventilator‐associated pneumonia:Guidelines for the management of hospital‐acquired pneumonia (HAP)/ventilator‐associated pneumonia (VAP) of the European respiratory society (ERS), European society of intensive care medicine (ESICM), European society of clinical microbiology and infectious diseases (ESCMID) and asociación latinoamericana del tórax (ALAT);Torres A;Eur Respir J,2017

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A scoping review of bacterial resistance among inpatients amidst the COVID-19 pandemic;Journal of Global Antimicrobial Resistance;2024-09

2. Evaluation of Antimicrobial Resistance Patterns of Pseudomonas aeruginosa Strains Isolated among COVID-19 Patients in Brazil Typed by Fourier-Transform Infrared Spectroscopy;Life;2024-08-29

3. Not only COVID-19: a systematic review of anti-COVID-19 measures and their effect on healthcare-associated infections;Journal of Hospital Infection;2024-05

4. Impact of infection prevention and control practices, including personal protective equipment, on the prevalence of hospital-acquired infections in acute care hospitals during COVID-19: a systematic review and meta-analysis;Journal of Hospital Infection;2024-05

5. Plant-Origin Components: New Players to Combat Antibiotic Resistance in Klebsiella pneumoniae;International Journal of Molecular Sciences;2024-02-10